Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer.
Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer. J Thorac Oncol. 2006 Mar; 1(3):245-51.